Truist lowered the firm’s price target on AdaptHealth (AHCO) to $12 from $13 and keeps a Buy rating on the shares. The firm is adjusting its model after the company’s Q3 results and updated FY24 guidance, the analyst tells investors in a research note. Truist is cutting its FY24 EPS view on AdaptHealth by 6c to 93c and its FY25 view by 15c to $1.04.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks